Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-16
2000-07-04
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514338, 514344, 514866, 544360, 544364, 546193, 546194, 5462684, 5462741, A61K 31445, C07D295194
Patent
active
060839600
ABSTRACT:
The present invention relates to a compound of general formula I ##STR1## for treating medical disorders related to binding to human somatostatin receptor subtypes.
REFERENCES:
patent: 4203988 (1980-05-01), Bolhofer et al.
patent: 5021431 (1991-06-01), Buschauer et al.
Woderer et al., Chem. Ber. 119, 2050-2054, (1986).
Ankersen Michael
Crider Albert Michael
Dorwald Florenzio Zaragoza
Stidsen Carsten Enggaard
Kumar Shailendra
Lambiris, Esq. Elias J.
Novo Nordisk A S
Zelson Esq. Steve T.
LandOfFree
Constrained somatostatin agonists and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Constrained somatostatin agonists and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Constrained somatostatin agonists and antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486893